Clinical Trial

Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery

Name: Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery — clinical trial record (NCT07515391)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 2

View on ClinicalTrials.gov →

Summary

This study evaluates the effect of SGLT-2 inhibitors (dapagliflozin) on the blood glucose excursions by a continuous glucose monitoring system, the incidence of hypoglycemia and hyperglycemia and change in glycated hemoglobin (HbA1c) level in people had bariatric surgery with and without type 2 diabetes.

Trial Details

NCT Number	NCT07515391
Lead Sponsor	Dasman Diabetes Institute Collaborators: Kuwait Foundation for the Advancement of Sciences
Conditions	Bariatric Surgery Candidate, Type2 Diabetes
Enrollment	30 participants
Start Date	2019-10-22
Primary Completion	2021-05-01 (estimated)
Study Completion	2026-10-22 (estimated)
Updated on ClinicalTrials.gov	2026-04-07